Pharmacokinetic–pharmacodynamic studies of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor MK-0916 in healthy subjects

AIMS: To characterize pharmacokinetic parameters of MK-0916 and its safety and tolerability in lean, healthy male subjects following single and multiple oral doses. To assess (by stable-isotope labelling) the in vivo inhibition of cortisone-to-cortisol conversion following oral MK-0916. METHODS: Dat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Wright, D Hamish, Stone, Julie A, Crumley, Tami M, Wenning, Larissa, Zheng, Wei, Yan, Kerri, Yang, Amy Yifan, Sun, Li, Cilissen, Caroline, Ramael, Steven, Hermanowski-Vosatka, Anne, Langdon, Ronald B, Gottesdiener, Keith M, Wagner, John A, Lai, Eseng
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Science Inc 2013
Assuntos:
Pharmacokinetic Dynamic Relationships
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3845315/
https://ncbi.nlm.nih.gov/pubmed/23594227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12131
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares